"Anqing Roundcare Pharmaceutical Co., Ltd. focuses on developing processes and improving production technologies for pharmaceutical intermediates and APIs. As a high-tech enterprise, we deliver custom synthesis, large-scale production of pharmaceutical intermediates, and APIs, offering related products and technical services to global pharmaceutical companies and research institutions."
Rooted in the chemical raw materials and API sector, Roundcare Pharmaceutical drives independent technological innovation and tackles technical challenges with determination. Our services span therapeutic areas such as oncology, antiviral, diabetes, cardiovascular, immune, and neurological systems. To enhance innovation efficiency, the company invests in advanced hardware and facilities, establishing a 5,600m² (60278 sq ft) R&D laboratory. This facility houses synthesis, pilot-scale labs, R&D analysis, and quality control labs, all equipped with state-of-the-art scientific equipment, along with a kilogram-scale GMP production workshop.

.png)
Our service principle : Everything for the customer, everything grounded in innovation.
Our company firmly believes that talent drives innovation and emphasizes building a strong talent pool. Our core technical team boasts high-level skills, strong innovation capabilities, and extensive practical experience, with over ten patents filed.
We closely monitor global trends in the biopharmaceutical industry, leveraging our existing technical and resource advantages to drive research and innovation, aiming to improve the survival and quality of life for patients worldwide. The company strives to become an internationally competitive, world-class provider of pharmaceutical research and production services, making drug development more efficient, accelerating time-to-market, and benefiting human health sooner.